Skip to main content
GNOM logo
GNOM
(NASDAQ)
Global X Genomics & Biotechnology ETF
$44.19-- (--)
Loading... - Market loading

GNOM ETF: Global X Genomics & Biotechnology ETF - Price, Holdings & Analysis

Global X Genomics & Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$43.11 - $44.23
52-Week High$51.42
52-Week Low$27.20
Open$43.11
Volume4.34K
Average Volume (3M)4.34K
Assets (AUM)49.36M
Expense Ratio0.50%
Total Holdings50
Inception DateApr 4, 2019
1 Day Change1.02%
1 Month Change-6.22%
6 Month Change9.09%
YTD Change-3.23%
1 Year Change38.44%
52-Week Change42.18%
5 Year Change-51.23%
50-Day MA$45.90
200-Day MA$41.76
RSI49.85
Stochastic %K81.45
Stochastic %D53.38
Annual Dividend$0.62
Dividend Yield1.41%
Last Dividend Ex-DateJul 7, 2026

Frequently Asked Questions About Global X Genomics & Biotechnology ETF

What is the current price of GNOM?

The latest GNOM price is $44.19. The 52-week range is $27.20–$51.42. GNOM has returned 42.2% over the past 52 weeks.

What is the expense ratio for GNOM?

GNOM's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does GNOM pay dividends?

Yes, GNOM pays a 1.41% dividend yield. The last ex-dividend date was 2026-07-07. View full dividend history in the Dividends section.

What are the top holdings of GNOM?

GNOM's largest holdings are Moderna, Inc. (8.2%), Praxis Precision Medicines, Inc. (6.6%), Arrowhead Pharmaceuticals, Inc (6.5%) (combined weight: 21.4%). The fund holds 50 total positions. View the complete portfolio breakdown in the Holdings section.

How does GNOM compare to similar ETFs?

Compare GNOM (0.50% expense ratio, $49M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.